Moclobemide Bupropion

Reports are on hand relating to more recent antidepressants such as bupropion, citalopram (Fairweather ei ul., 1997), fluoxetine (Gelfin et ul.. 1998). moclobemide (Dingemanse et ul., 1998) and paroxetine (Brauer et ul.. 1995). These products, in agreement with their clinical profiles, produce fewer subjective effects and generally less sedation in healthy subjects than the older... 

Area of assessment Clinically sedative antidepressants, e.g. amitriptyline, mianserin, trimipramine Less sedative antidepressants, e.g. bupropion, fluoxetin, moclobemide, nefazodone ... 

Simultaneous amoxapine, clovoxamine, desipramine, fenfluramine, fluvoxamine, nor-fluoxetine, nortriptyline, propranolol, protriptyline, sertraline Noninterfering amitriptyline, atenolol, bupropion, carbamazepine, chlordiazepoxide, ci-talopram, clomipramine, clozapine, cyclobenzaprine, doxepin, imipramine, loxapine, me-toprolol, mianserin, moclobemide, nomifensine, pindolol, thioridazine, tranyl[Pg.626]

For MDD with seasonal pattern (MDDSP), bright-light therapy is the first-line treatment. Fiuoxetine and moclobemide are second-line treatments. Bupropion, citalopram, and tranylcypromine are third-line treatments. 

Finally, we have assayed the in vivo antidepressant effect of a natural phenolic compound, frans-resveratrol, and an oxoisoaporphine derivative, 5-methoxy-7/f-dibenzo[Je,/i]quinolin-7-one, 0X0 4 (Figime 12). The antidepressant-like effect of trans-resveratrol and 0X0 4 was evaluated through a Forced Swimming Test (FST), and they were compared with reference antidepressants imipramine, desipramine, nomifensine, bupropion, nisoxetine, citalopram and moclobemide. In this sense, we evaluate 0X0 4 at 15, 30 and 45 min. affording the mayor reduction at 30 min after the administration. 

Noninterfering amitriptyline, bupropion, citalopram, clomipramine, clozapine, dox-epin, haloperidol, 2-hydroxydesipramine, 2-hydroxyimipramine, imipramine, loxapine, moclobemide, olanzapine, risperidone... 

---